CMPS COMPASS Pathways plc

8.650USD+6.53%Mkt Cap: 1.23B USDP/E: —

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial…